The full invitation to the AGM 2025 may be found in the General Meetings section of the Company's website here.

Home > Press release: Successful Development of Innovative and ...

Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment ...

Genmab A/S (NASDAQ:GMAB) has announced promising new data for its investigational antibody-drug conjugate, rinatabart ...

Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.

A doctor has revealed that there are 5 daily diet changes that people should try to help ease their pain. Dr Safia Debar, ...

He says some people don’t find out they have Cystic Fibrosis until they are adults. The test to diagnose adults is called a ...

Commercialization has started for network switches based on co-packaged optics (CPO), which are capable of routing signals at ...

AstraZeneca's camizestrant and Pfizer's vepdegestrant extended progression-free survival in trials in advanced ESR1-mutated breast cancer.

BOSTON, Massachusetts, USA, 3 June 2025 – In a comprehensive Genomic Press Interview published today, Dr. Erin E. Mauney reveals how her pioneering ...